Related Experiment Videos
Cardiomyopathy in phaeochromocytoma: a case report
A Villani1, P Primieri, G De Cosmo
1Istituto di Anestesiologia e Rianimazione, Universita Cattalica S. Cuore, Rome, Italy.
European Journal of Anaesthesiology
|May 1, 1989
Summary
Anesthetic management for bilateral phaeochromocytoma with cardiomyopathy used sodium nitroprusside and verapamil to control hypertension and tachycardia. Verapamil effectively managed rhythm disturbances and blood pressure, with stable cardiac index, offering a potential treatment strategy.
Area of Science:
- Cardiology
- Anesthesiology
- Endocrinology
Background:
- Phaeochromocytoma, a rare neuroendocrine tumor, presents significant anesthetic challenges due to catecholamine release.
- Cardiomyopathy complicates management, increasing risks of hemodynamic instability during tumor manipulation.
- Managing hypertension and supraventricular tachycardia is critical for patient safety.
Observation:
- A case report detailing the anesthetic management of a patient with bilateral phaeochromocytoma and co-existing cardiomyopathy.
- Hemodynamic parameters were monitored closely during surgical resection.
- The patient experienced hypertension and supraventricular tachycardia, common complications of phaeochromocytoma.
Findings:
- Sodium nitroprusside and verapamil were administered to control blood pressure and heart rhythm.
- Verapamil effectively managed supraventricular rhythm disturbances and arterial blood pressure.
- Cardiac index remained stable throughout the procedure and post-operatively.
Implications:
- Verapamil demonstrates utility in managing hemodynamic and rhythm disturbances associated with phaeochromocytoma.
- The readily reversible nature of verapamil's side effects with calcium chloride enhances its safety profile.
- This case suggests verapamil as a valuable agent in the anesthetic management of complex phaeochromocytoma cases.